MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/00016340802460297

Медицинская библиотека · Acta obstetricia et gynecologica Scandinavica · 2008

Prenatal buprenorphine exposure: effects on biochemical markers of hypoxia and early neonatal outcome.

Kahila Hanna, Stefanovic Vedran, Loukovaara Mikko, Alfthan Henrik, Hämäläinen Esa, Halmesmäki Erja

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To evaluate the possible association between prenatal buprenorphine exposure and compromised early neonatal outcome in view of markers of perinatal hypoxia. DESIGN, SETTING AND SAMPLE: The study group consisted of 27 full-term neonates exposed to buprenorphine prenatally and prospectively followed up at a special tertiary outpatient clinic for pregnant drug abusers. Serving as controls were 27 full-term neonates exposed prenatally to illicit substances other than opioids and 38 full-term neonates from uncomplicated pregnancies of healthy parturients.

METHODS AND MAIN OUTCOME MEASURES: Apgar scores, cord pH and base excess were recorded. Cord serum samples were collected at birth for analysis of biochemical markers of fetal hypoxic stress: erythropoietin (EPO; chronic hypoxia), cardiac troponin T (cardiac involvement) and S100 (neural damage).

RESULTS

All infants were born in good condition according to Apgar scores and pH of cord blood. No statistically significant differences were found between the three groups in cord serum concentrations of EPO (33.0 median, range: 9.0-476.0 U/L in the buprenorphine-exposed group vs 27.0, range: 8.0-114.0 U/L in substance-abusing controls vs 28.1, range: 11.6-260.0 U/L in healthy controls) or S100 (0.47, range: 0.25-0.91 microg/L vs 0.40, range: 0.12-1.22 microg/L vs 0.47, range: 0.20-2.15 microg/L). No significant differences existed in cardiac TnT levels (0.017, range: 0.010-0.072 U/L vs 0.010, range: 0.010-0.075 U/L vs 0.024, range: 0.010-0.075 U/L).

CONCLUSIONS

While no significant differences in asphyxia markers were observed between the three groups, a tendency towards higher levels of EPO emerged in the buprenorphine-exposed group.

Для цитирования: Kahila Hanna, Stefanovic Vedran, Loukovaara Mikko, Alfthan Henrik, Hämäläinen Esa, Halmesmäki Erja. Prenatal buprenorphine exposure: effects on biochemical markers of hypoxia and early neonatal outcome.. Acta obstetricia et gynecologica Scandinavica. 2008. DOI: 10.1080/00016340802460297.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.